Dr. Knowlton has won numerous awards for his leadership in pharmacy, business, and philanthropy in his career of over 30 years, including the 2003 and the 2013 Ernest and Young Entrepreneur of the Year Award, Greater Philadelphia Region, and the 2004 Walter M. Aikman Entrepreneur of the Year Award. He was selected as the Most Influential U.S. Pharmacist in 1997. He has been elected and served as the national President for the American College of Apothecaries, President of the American Pharmacists Association (APhA) for two terms, and President of the American Pharmacists Association Foundation.
Knowlton currently serves on the Board of the Coriell Institute for Medical Research and the Evergreens Continuing Care Retirement Community. He chairs the Board of Coriell Life Sciences, Inc., and serves on the Board of the Cooper Medical School of Rowan University. He serves on the Board (Session) of the First Presbyterian Church in Moorestown NJ and chairs their Long Range Planning Panel. He recently finished his term on the Board of St Christopher’s Hospital for Children in Philadelphia. He is a member of the APhA Pharmacogenomics Task Force, as well as the FDA-recognized National Pharmacogenomics Advisory Group.
Knowlton is the Founder and CEO of CareKinesis, the first national PACE Medication Risk Mitigation Company. CareKinesis is the tenth company he has founded. excelleRx/Hospice Pharmacia was his most recent company prior to CareKinesis. In the aggregate, his companies have employed more than 1,300 people—mostly pharmacists, technicians and administrative types. Launched in 2010, CareKinesis has already been showcased by the:
- SmartCEO Voltage Award, Technology Innovator, Large Company, 2014
- E & Y Entrepreneur of the Year, Healthcare Sector, Greater Philadelphia Region, 2013
- Garden State Entrepreneur Excellence Award, for 2013
- Philadelphia Business Journal, Best Places to Work 2012
- NJ Technology Council, 2012 Growth Company of the Year
- IMPACT2012, Featured Company
- NJ Economic Development Authority, job-growth funding recipient for 2012 & 2013
- Greater Philadelphia Alliance for Capital and Technologies, 2011 Enterprise Awards, Life Science Start-up Company of the Year
Knowlton received his pharmacy degree from Temple University, his Divinity degree from Princeton Theological Seminary, and his PhD in pharmacoeconomics from the University of Maryland. He served as Professor and Department Chair for the University of the Sciences in Philadelphia in the 1990s. He has authored and co-authored text books, book chapters, and articles focused on the role and responsibility of pharmacists in the outcomes of patient-centered medication care.